Related Experiment Video
Updated: May 6, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Scaling up pre-exposure prophylaxis: A global analysis of processes and challenges regarding the implementation of
Junior M Ntimani1, Andile G Mokoena-de Beer, Deliwe R Phetlhu
1Department of Nursing Science, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, Pretoria. Jmntimani@gmail.com.
Background:
Pre-exposure prophylaxis (PrEP) guideline implementation varies widely across countries as a result of differences in health systems, resources, and HIV priorities. Since 2016, oral PrEP has been available to key populations, yet limited evidence exists on how implementation challenges differ across contexts.
Objectives:
This review aimed to explore the processes and challenges in the implementation of PrEP guidelines globally.
Method:
An integrative review method was used by searching electronic databases, including PubMed, Medline, EBSCOhost, CINAHL, and Google Scholar, to extract the data. We included qualitative, quantitative, and mixed-method studies relevant to the global implementation of PrEP published in peer-reviewed English journals from 2019 through 2025.
Results:
This study emphasises that worldwide PrEP implementation is complex and adaptable, involving progressive provider engagement, task-shifting, and health system integration. Stigma and misunderstandings about PrEP, including structural barriers such as a lack of coverage recognition and supply chain difficulties at odds with the maintenance phase needed to scale up availability, are challenges.
Conclusion:
Progress on global PrEP coverage has been blunted by persisting challenges in dismantling structural, financial, and geopolitical blockades to universal access. The model will work if it is implemented with community outreach and creative service delivery, including education, training, and outreach. Structural inequalities need to be considered and crisis-affected communities prioritised to ensure that access is equitable and sustainable. Implemented at scale, PrEP could be a game changer for HIV prevention globally, especially in high-burden countries.Contribution: This study contributes by synthesising evidence on global PrEP guideline implementation, highlighting health system, structural, and societal challenges.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Preclinical Development: Overview
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Therapeutic Drug Monitoring: Affecting Factors
Clinical Trials: Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion

